Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Eros International, and Teva Pharmaceutical Industries and Encourages Investors to Contact the Firm
03 juil. 2019 08h30 HE
|
Bragar Eagel & Squire
NEW YORK, July 03, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Pivotal Software, Inc., Eros...
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
02 juil. 2019 10h27 HE
|
Schall Law
LOS ANGELES, July 02, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical...
Bragar Eagel & Squire Reminds Investors That Class Action Lawsuits have been filed against Pivotal Software, Eros International, and Teva Pharmaceutical Industries and Encourages Investors to Contact the Firm
27 juin 2019 21h30 HE
|
Bragar Eagel & Squire
NEW YORK, June 27, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel and Squire reminds investors that class action lawsuits have been filed on behalf of stockholders of Pivotal Software, Inc., Eros...
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
27 juin 2019 10h47 HE
|
Schall Law
LOS ANGELES, June 27, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical...
AbCellera Announces Expanded Research Collaboration with Teva
13 juin 2017 09h00 HE
|
AbCellera
VANCOUVER, British Columbia, June 13, 2017 (GLOBE NEWSWIRE) -- AbCellera Biologics, Inc. announced today a new therapeutic antibody discovery collaboration with Teva Pharmaceutical Industries, Ltd....
TEVA REMINDER: Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important January 5 Deadline in Class Action Filed by Firm- TEVA
27 déc. 2016 09h00 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 27, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the American Depositary Shares (“ADSs”) of Teva Pharmaceutical Industries Limited...
Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA
12 déc. 2016 18h23 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 12, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the American Depositary...
Mesoblast Chairman's Address to 2015 Annual General Meeting
22 oct. 2015 02h00 HE
|
Mesoblast
NEW YORK, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Thank you for attending the Mesoblast 2015 Annual General Meeting.
This has been another exciting and productive year in the history of our...
Phase 2 Trial Results Show Mesoblast Cell Therapy Has Greatest Cardioprotective Effect In Patients With Advanced Heart Failure
29 sept. 2015 21h10 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; USOTC:MBLTY) today announced that additional Phase 2 trial results of its lead product candidate for...